EquityZen Growth Technology Fund LLC - Series 1222
Raised
$660K
Investors
30
Min Invest
$10,010
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1222 is a Delaware-organized pooled investment vehicle filed by EquityZen Advisors LLC, raising $660K from 30 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1). This is an amended filing for a series within the EquityZen platform, which operates nearly 1,900 pre-IPO investment vehicles.
This pre-IPO fund follows a standard EquityZen platform structure: small-series pooled vehicles with accessible minimums ($10K) enabling retail-adjacent access to private company equity via Rule 506(b) private placements exempt from Investment Company Act registration under Section 3(c)(1). The $22K average commitment across 30 investors is consistent with EquityZen's SPV-series model for fractionalizing pre-IPO positions.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
